FDA Approvals

Date Posted
Article Title
7/18/2017
Nerlynx Approved to Help Prevent Breast Cancer's Return

Drug is designed to block cancer-fueling enzymes

5/24/2017
New Drug Approved for All Cancers With Genetic Marker

First medication sanctioned for any cancer, regardless of origin

5/22/2017
Actemra Approved for Certain Blood Vessel Inflammation

Drug will treat adults with a condition called vasculitis

5/18/2017
Kalydeco Approval Widened for More Types of Cystic Fibrosis

Laboratory evidence used to expand approval

5/15/2017
New Device Approved for Esophageal Birth Defect

Condition affects 1 in 2,500 babies in U.S.

4/28/2017
Rydapt Approved for Adults With Acute Myeloid Leukemia

A blood cancer that forms in the bone marrow

4/28/2017
Brineura Approved for Rare Genetic Illness Affecting Kids

Batten disease is a neurologic disorder that typically affects young children

4/27/2017
Stivarga Approved for Liver Cancer

First approved treatment for this disease in years

4/12/2017
1st Drug for Tardive Dyskinesia Approved

Condition characterized by involuntary movement of the jaw, lips and tongue

4/7/2017
FDA Approves Hep C Drugs for Kids 12 and Older

Previously allowed only for adults

4/6/2017
FDA Approves 1st Direct-to-Consumer Genetic Risk Tests

They screen for gene variants linked to 10 diseases and conditions

3/29/2017
Ocrevus Approved to Treat Severe Form of Multiple Sclerosis

First drug sanctioned in U.S. for primary progressive MS

3/28/2017
Dupixent Approved to Treat Eczema

When topical medication doesn't work

3/28/2017
Zejula Approved for Certain Female Cancers

Drug may help fight tumors affecting the ovaries, fallopian tubes or abdominal wall

3/23/2017
Bavencio Approved for Rare Skin Cancer

First sanctioned treatment in U.S. for aggressive tumor

3/22/2017
New Parkinson's Drug Xadago Approved

To help prevent 'off' episodes among users of levodopa/carbidopa

3/6/2017
Noctiva Approved for Frequent Urination at Night

For adults who awaken to urinate at least twice nightly

3/1/2017
Xermelo Approved for Tumor-Related Diarrhea

Drug will treat a condition called carcinoid syndrome diarrhea

2/16/2017
Siliq Approved for Plaque Psoriasis

Injected drug is for use by patients who've failed other treatments

2/9/2017
Emflaza Approved for Duchenne Muscular Dystrophy

First U.S. approval of corticosteroid to treat the disorder